Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes

Min Wang, Ji Quan Wang, Mingzhang Gao, Qi-Huang Zheng

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Rivastigmine is a newer-generation inhibitor with a dual inhibitory action on both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes, and is used for the treatment of AChE- and BChE-related diseases such as brain Alzheimer's disease and cardiovascular disease. New carbon-11 labeled conformationally restricted rivastigmine analogues radiolabeled quaternary ammonium triflate salts, (3aR,9bS)-1-[11C]methyl-1-methyl-6-(methylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]8) and (3aR,9bS)-1-[11C]methyl-1-methyl-6-(heptylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]9), were designed and synthesized as potential positron emission tomography (PET) agents for imaging AChE and BChE enzymes. The appropriate precursors were labeled with [11C]CH3OTf through N-[11C]methylation, and the target tracers were isolated by solid-phase extraction (SPE) using a cation-exchange CM Sep-Pak cartridge in 40-50% radiochemical yields decay corrected to end of bombardment (EOB), 15-20 min overall synthesis time, and 148-222 GBq/μmol specific activity at EOB.

Original languageEnglish
Pages (from-to)506-512
Number of pages7
JournalApplied Radiation and Isotopes
Volume66
Issue number4
DOIs
StatePublished - Apr 2008

Fingerprint

enzymes
positrons
tomography
analogs
bombardment
carbon
synthesis
cartridges
methylation
inhibitors
brain
tracers
solid phases
salts
cations
decay

Keywords

  • Acetylcholinesterase (AChE)
  • Butyrylcholinesterase (BChE)
  • Carbon-11
  • Conformationally restricted analogues
  • Imaging
  • Positron emission tomography (PET)
  • Rivastigmine

ASJC Scopus subject areas

  • Radiation

Cite this

Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes. / Wang, Min; Wang, Ji Quan; Gao, Mingzhang; Zheng, Qi-Huang.

In: Applied Radiation and Isotopes, Vol. 66, No. 4, 04.2008, p. 506-512.

Research output: Contribution to journalArticle

@article{7f621c1ded3f49c09418e70f3ce037d4,
title = "Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes",
abstract = "Rivastigmine is a newer-generation inhibitor with a dual inhibitory action on both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes, and is used for the treatment of AChE- and BChE-related diseases such as brain Alzheimer's disease and cardiovascular disease. New carbon-11 labeled conformationally restricted rivastigmine analogues radiolabeled quaternary ammonium triflate salts, (3aR,9bS)-1-[11C]methyl-1-methyl-6-(methylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]8) and (3aR,9bS)-1-[11C]methyl-1-methyl-6-(heptylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]9), were designed and synthesized as potential positron emission tomography (PET) agents for imaging AChE and BChE enzymes. The appropriate precursors were labeled with [11C]CH3OTf through N-[11C]methylation, and the target tracers were isolated by solid-phase extraction (SPE) using a cation-exchange CM Sep-Pak cartridge in 40-50{\%} radiochemical yields decay corrected to end of bombardment (EOB), 15-20 min overall synthesis time, and 148-222 GBq/μmol specific activity at EOB.",
keywords = "Acetylcholinesterase (AChE), Butyrylcholinesterase (BChE), Carbon-11, Conformationally restricted analogues, Imaging, Positron emission tomography (PET), Rivastigmine",
author = "Min Wang and Wang, {Ji Quan} and Mingzhang Gao and Qi-Huang Zheng",
year = "2008",
month = "4",
doi = "10.1016/j.apradiso.2007.11.005",
language = "English",
volume = "66",
pages = "506--512",
journal = "Applied Radiation and Isotopes",
issn = "0969-8043",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes

AU - Wang, Min

AU - Wang, Ji Quan

AU - Gao, Mingzhang

AU - Zheng, Qi-Huang

PY - 2008/4

Y1 - 2008/4

N2 - Rivastigmine is a newer-generation inhibitor with a dual inhibitory action on both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes, and is used for the treatment of AChE- and BChE-related diseases such as brain Alzheimer's disease and cardiovascular disease. New carbon-11 labeled conformationally restricted rivastigmine analogues radiolabeled quaternary ammonium triflate salts, (3aR,9bS)-1-[11C]methyl-1-methyl-6-(methylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]8) and (3aR,9bS)-1-[11C]methyl-1-methyl-6-(heptylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]9), were designed and synthesized as potential positron emission tomography (PET) agents for imaging AChE and BChE enzymes. The appropriate precursors were labeled with [11C]CH3OTf through N-[11C]methylation, and the target tracers were isolated by solid-phase extraction (SPE) using a cation-exchange CM Sep-Pak cartridge in 40-50% radiochemical yields decay corrected to end of bombardment (EOB), 15-20 min overall synthesis time, and 148-222 GBq/μmol specific activity at EOB.

AB - Rivastigmine is a newer-generation inhibitor with a dual inhibitory action on both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes, and is used for the treatment of AChE- and BChE-related diseases such as brain Alzheimer's disease and cardiovascular disease. New carbon-11 labeled conformationally restricted rivastigmine analogues radiolabeled quaternary ammonium triflate salts, (3aR,9bS)-1-[11C]methyl-1-methyl-6-(methylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]8) and (3aR,9bS)-1-[11C]methyl-1-methyl-6-(heptylcarbamoyloxy)-2,3,3a,4,5,9b-hexahydro-1H-benzo[g]indolium triflate ([11C]9), were designed and synthesized as potential positron emission tomography (PET) agents for imaging AChE and BChE enzymes. The appropriate precursors were labeled with [11C]CH3OTf through N-[11C]methylation, and the target tracers were isolated by solid-phase extraction (SPE) using a cation-exchange CM Sep-Pak cartridge in 40-50% radiochemical yields decay corrected to end of bombardment (EOB), 15-20 min overall synthesis time, and 148-222 GBq/μmol specific activity at EOB.

KW - Acetylcholinesterase (AChE)

KW - Butyrylcholinesterase (BChE)

KW - Carbon-11

KW - Conformationally restricted analogues

KW - Imaging

KW - Positron emission tomography (PET)

KW - Rivastigmine

UR - http://www.scopus.com/inward/record.url?scp=39649090068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39649090068&partnerID=8YFLogxK

U2 - 10.1016/j.apradiso.2007.11.005

DO - 10.1016/j.apradiso.2007.11.005

M3 - Article

VL - 66

SP - 506

EP - 512

JO - Applied Radiation and Isotopes

JF - Applied Radiation and Isotopes

SN - 0969-8043

IS - 4

ER -